Skip to content
PICO Portalanswers from OpenAlex

EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer

PaperCitations, authors & open-access status

EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer is a paper indexed in PICO Portal from OpenAlex.

How many citations does EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer have?

PICO Portalcitation count

EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer has 372 citations in the OpenAlex counts PICO Portal stores.

When was EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer published?

PICO Portalyear

EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer has 2019 year in the PICO Portal index.

What is the open-access status of EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer?

PICO Portaloa status

EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer has bronze oa status in the PICO Portal index.

What is the DOI of EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer?

PICO Portaldoi

The DOI for EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer is on the source record.

What is the PMID of EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer?

PICO Portalpmid

The PMID for EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer is on the source record.

What is the OpenAlex record for EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer?

PICO Portalopenalex

The OpenAlex for EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial